CS logo
small CS logo
Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility

Southampton, United Kingdom

About Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility


During the past decade, Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
2007-10-12
2024-12-01
Active, not recruiting
701
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
2008-03-01
Active, not recruiting
731
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2012-06-18
Unknown status
1,070
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
2009-01-29
2023-09-21
Active, not recruiting
247
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
2009-09-01
Recruiting
360
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
2009-06-29
2024-07-28
Active, not recruiting
813

Rows per page:

1–100 of 191

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "University Hospital Southampton NHS Foundation Trust" with 3 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility


According to Clinical.Site data, the most researched conditions in "Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility" are "Meningitis, Bacterial" (3 trials), "Crohn's Disease" (2 trials), "Influenza" (2 trials), "Ulcerative Colitis" (2 trials) and "Neisseria Infection" (1 trials). Many other conditions were trialed in "Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility" in a lesser frequency.

Clinical Trials Intervention Types at Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility


Most popular intervention types in "Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility" are "Drug" (5 trials), "Biological" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Filgotinib" (4 trials), "N. lactamica" (2 trials), "Placebo" (2 trials), "Baxter Novel Influenza A H1N1 Whole Virus Vaccine" (1 trials) and "GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility


The vast majority of trials in "Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility" are 9 trials for "All" genders.

Clinical Trials Status at Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility


Currently, there are NaN active trials in "Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status